Clinical Trials List
2016-08-01 - 2018-12-31
Phase III
Terminated7
ICD-10A49.8
Other bacterial infections of unspecified site
ICD-10B96.89
Other specified bacterial agents as the cause of diseases classified elsewhere
ICD-9041.89
Other specified bacterial infections of unspecified site
-
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
Co-Principal Investigator
- 陳垚生 Division of Infectious Disease
- 林聖哲 Division of Infectious Disease
- 吳冠陞 Division of Infectious Disease
- 陳瑞光 Division of Infectious Disease
- 趙珮娟 Division of Infectious Disease
- 曾鈺婷 Division of Infectious Disease
- 施正蓮 Division of Infectious Disease
- 周稚偵 Division of Infectious Disease
- 翁雅為 Division of Infectious Disease
- 洪宛廷 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 趙文震 Division of Infectious Disease
- Pin-Kuei Fu Division of Infectious Disease
- Chien-Hua Tseng Division of Infectious Disease
- 王俊隆 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ling Ju Huang Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Chao Lin Division of Infectious Disease
- 梁信杰 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jann-Tay Wang Division of Infectious Disease
- - - Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
200 participants
